ICCC
Price
$6.06
Change
-$0.14 (-2.26%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
56.08M
54 days until earnings call
JANX
Price
$22.81
Change
-$0.17 (-0.74%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
1.38B
48 days until earnings call
Interact to see
Advertisement

ICCC vs JANX

Header iconICCC vs JANX Comparison
Open Charts ICCC vs JANXBanner chart's image
ImmuCell
Price$6.06
Change-$0.14 (-2.26%)
Volume$200
Capitalization56.08M
Janux Therapeutics
Price$22.81
Change-$0.17 (-0.74%)
Volume$58.28K
Capitalization1.38B
ICCC vs JANX Comparison Chart in %
Loading...
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICCC vs. JANX commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICCC is a Hold and JANX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (ICCC: $6.20 vs. JANX: $22.98)
Brand notoriety: ICCC and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICCC: 24% vs. JANX: 60%
Market capitalization -- ICCC: $56.08M vs. JANX: $1.38B
ICCC [@Biotechnology] is valued at $56.08M. JANX’s [@Biotechnology] market capitalization is $1.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICCC’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • ICCC’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, ICCC is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICCC’s TA Score shows that 5 TA indicator(s) are bullish while JANX’s TA Score has 2 bullish TA indicator(s).

  • ICCC’s TA Score: 5 bullish, 3 bearish.
  • JANX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ICCC is a better buy in the short-term than JANX.

Price Growth

ICCC (@Biotechnology) experienced а +5.08% price change this week, while JANX (@Biotechnology) price change was -1.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

ICCC is expected to report earnings on Nov 17, 2025.

JANX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.38B) has a higher market cap than ICCC($56.1M). ICCC YTD gains are higher at: 20.388 vs. JANX (-57.079). ICCC has higher annual earnings (EBITDA): 4.96M vs. JANX (-142.8M). JANX has more cash in the bank: 996M vs. ICCC (6M). ICCC has less debt than JANX: ICCC (14.3M) vs JANX (22.2M). ICCC has higher revenues than JANX: ICCC (28.3M) vs JANX (439K).
ICCCJANXICCC / JANX
Capitalization56.1M1.38B4%
EBITDA4.96M-142.8M-3%
Gain YTD20.388-57.079-36%
P/E Ratio29.52N/A-
Revenue28.3M439K6,446%
Total Cash6M996M1%
Total Debt14.3M22.2M64%
FUNDAMENTALS RATINGS
ICCC: Fundamental Ratings
ICCC
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
44
SEASONALITY SCORE
1..100
10

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ICCCJANX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ICCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HWACX37.420.02
+0.05%
Hotchkis & Wiley Value Opps C
FTHNX49.47-0.04
-0.08%
FullerThaler Behavioral Sm-Cp Eq Inv
PCVCX9.81-0.02
-0.20%
Virtus NFJ Small-Cap Value C
PGRTX16.36-0.07
-0.43%
Principal SmallCap Growth I Instl
STPCX13.30-0.23
-1.70%
Saratoga Technology & Comm C

ICCC and

Correlation & Price change

A.I.dvisor tells us that ICCC and UNCY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ICCC and UNCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCC
1D Price
Change %
ICCC100%
-0.80%
UNCY - ICCC
29%
Poorly correlated
+0.51%
JANX - ICCC
26%
Poorly correlated
-2.25%
CDTX - ICCC
24%
Poorly correlated
-2.62%
MYNDF - ICCC
24%
Poorly correlated
N/A
NERV - ICCC
23%
Poorly correlated
+0.32%
More

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with SNTI. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then SNTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
-2.25%
SNTI - JANX
43%
Loosely correlated
N/A
CYCN - JANX
41%
Loosely correlated
-0.66%
NUVL - JANX
40%
Loosely correlated
+2.76%
TERN - JANX
39%
Loosely correlated
-0.40%
PPBT - JANX
36%
Loosely correlated
+2.19%
More